Dorsey & Whitney Trust CO LLC Sells 356 Shares of HCA Healthcare, Inc. $HCA

Dorsey & Whitney Trust CO LLC reduced its stake in shares of HCA Healthcare, Inc. (NYSE:HCA) by 21.7% in the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 1,284 shares of the company’s stock after selling 356 shares during the quarter. Dorsey & Whitney Trust CO LLC’s holdings in HCA Healthcare were worth $492,000 at the end of the most recent quarter.

Other large investors also recently added to or reduced their stakes in the company. Cheviot Value Management LLC purchased a new position in shares of HCA Healthcare during the first quarter worth approximately $26,000. Saudi Central Bank bought a new stake in HCA Healthcare during the 1st quarter valued at $26,000. WPG Advisers LLC bought a new position in shares of HCA Healthcare during the 1st quarter worth $27,000. Ameriflex Group Inc. bought a new stake in shares of HCA Healthcare in the second quarter valued at about $27,000. Finally, Chung Wu Investment Group LLC bought a new position in HCA Healthcare during the 2nd quarter worth about $27,000. 62.73% of the stock is owned by hedge funds and other institutional investors.

Insider Transactions at HCA Healthcare

In related news, EVP Michael S. Cuffe sold 3,836 shares of the company’s stock in a transaction that occurred on Monday, September 8th. The stock was sold at an average price of $418.84, for a total value of $1,606,670.24. Following the sale, the executive vice president owned 31,503 shares in the company, valued at $13,194,716.52. This represents a 10.85% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, EVP Michael R. Mcalevey sold 3,892 shares of HCA Healthcare stock in a transaction that occurred on Wednesday, November 5th. The shares were sold at an average price of $473.79, for a total transaction of $1,843,990.68. Following the sale, the executive vice president owned 3,487 shares of the company’s stock, valued at approximately $1,652,105.73. The trade was a 52.74% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders own 1.30% of the company’s stock.

HCA Healthcare Stock Up 0.7%

HCA opened at $481.68 on Thursday. The firm’s 50-day moving average price is $437.79 and its 200-day moving average price is $399.25. The company has a market cap of $109.92 billion, a P/E ratio of 18.62, a price-to-earnings-growth ratio of 1.38 and a beta of 1.41. HCA Healthcare, Inc. has a 52-week low of $289.98 and a 52-week high of $484.31.

HCA Healthcare (NYSE:HCA) last issued its quarterly earnings results on Friday, October 24th. The company reported $6.96 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $5.64 by $1.32. The business had revenue of $19.16 billion for the quarter, compared to analyst estimates of $18.55 billion. HCA Healthcare had a net margin of 8.53% and a negative return on equity of 792.25%. HCA Healthcare’s revenue for the quarter was up 9.6% compared to the same quarter last year. During the same quarter in the prior year, the business posted $4.90 EPS. HCA Healthcare has set its FY 2025 guidance at 27.000-28.000 EPS. On average, research analysts anticipate that HCA Healthcare, Inc. will post 24.98 EPS for the current fiscal year.

HCA Healthcare Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Monday, December 29th. Stockholders of record on Monday, December 15th will be issued a $0.72 dividend. The ex-dividend date of this dividend is Monday, December 15th. This represents a $2.88 dividend on an annualized basis and a dividend yield of 0.6%. HCA Healthcare’s dividend payout ratio is currently 11.13%.

Analyst Ratings Changes

A number of research firms have recently issued reports on HCA. Cantor Fitzgerald reiterated an “overweight” rating on shares of HCA Healthcare in a research note on Monday, October 27th. Oppenheimer increased their target price on HCA Healthcare from $400.00 to $500.00 and gave the company an “outperform” rating in a research report on Monday, October 27th. Cowen reaffirmed a “buy” rating on shares of HCA Healthcare in a research report on Monday, October 27th. Zacks Research upgraded shares of HCA Healthcare from a “hold” rating to a “strong-buy” rating in a report on Wednesday, October 29th. Finally, Robert W. Baird boosted their price objective on shares of HCA Healthcare from $380.00 to $423.00 and gave the stock a “neutral” rating in a research note on Thursday, August 14th. One investment analyst has rated the stock with a Strong Buy rating, fourteen have given a Buy rating and ten have issued a Hold rating to the company. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $474.53.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.